Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software Press Release Certara 发布新一代 CoAuthor™ 生成式人工智能法规撰写软件 AI-enabled solutions accelerate regulatory and medical writing processes, enhancing quality, transparency, and efficiencies RADNOR, PA…Danielle Pillsbury2024 年 6 月 17 日
Introducing CoAuthor™: The Gen-AI Enabled Solution for Regulatory Writers On-Demand Webinar 介绍 CoAuthor™: 面向法规撰写者的 Gen-AI 解决方案 Faced with more (and more complex) clinical research than ever before, regulatory writers are facing…Danielle Pillsbury2024 年 6 月 14 日
Certara Recognized as a Top Biopharma Workplace for 2024 Announcement Certara Recognized as a Top Biopharma Workplace for 2024 RADNOR, PA – 2024 年 6 月 12 日 – Certara, Inc. (纳斯达克股票代码:CERT), a global leader in…Danielle Pillsbury2024 年 6 月 12 日
How QSP Brings Insights and Accelerates Bispecific Antibody Drug Development [China Webinar] On-Demand Webinar 深入探索QSP如何加速双特异性抗体药物开发进程【中国网络讲座】 More than 50 bispecific antibodies are in oncology clinical development with a large diversity in…Danielle Pillsbury2024 年 6 月 7 日
Adaptive Trial Design for Phase 1 Dose-Finding Studies On-Demand Webinar Adaptive Trial Design for Phase 1 Dose-Finding Studies Greater flexibility, efficiency and quicker dissemination of research findings to patient communities that stand to…Danielle Pillsbury2024 年 6 月 7 日
A Best Practice Guide to CRF Design Guide CRF 设计最佳实践指南 Design quality, effective and reusable case report forms with our CRF Design Guide. Download the…Simona Colucci2024 年 6 月 7 日
The State of Generative AI in Life Sciences White Paper 生命科学生成式人工智能的现状 Discover how Generative AI in life sciences can transform drug discovery, clinical trials, and lab…Danielle Pillsbury2024 年 6 月 7 日
Clinical trial data validation: When to transition from P21 Community to Enterprise Blog Clinical trial data validation: When to transition from P21 Community to Enterprise Technology is designed to help us live and work smarter. That is exactly what P21’s…Simona Colucci2024 年 6 月 7 日
Technology Networks: Deregulating Psychedelics To Propel Clinical Research Article Technology Networks: Deregulating Psychedelics To Propel Clinical Research Deregulating certain psychedelics could help to address unmet patient needs.Danielle Pillsbury2024 年 6 月 6 日